365Telugu.com online news,Bengaluru, February 28, 2025: Marking Rare Disease Day, Strand Life Sciences, a Reliance Industries subsidiary and a leader in genomics, has launched the StrandOmics Portal-an advanced online platform designed to assist doctors in diagnosing rare diseases more efficiently.
The StrandOmics Portal enables clinicians to quickly access and analyze genetic variant data, offering a comprehensive case-by-case view, which enhances diagnostic accuracy and reduces turnaround time.
Read this also…Reliance Foundation Announces Postgraduate Scholarships 2024-25 Results on National Science Day
ఇది కూడా చదవండి...జీవనశైలి రుగ్మతలకు రెండు కారణాలు ఉన్నాయి..? అవేంటంటే..?
In line with its commitment to accessibility, Strand Life Sciences is also introducing discounted rare disease genetic testing for patients from economically disadvantaged backgrounds, ensuring that essential diagnostics remain within reach for all.
Key Benefits of the StrandOmics Portal:
*Faster and clearer genetic insights for precise rare disease diagnosis
*Expanded genetic variant analysis, allowing independent clinical review
*Enhanced prenatal diagnostics through improved collaboration among specialists
Dr. Ramesh Hariharan, CEO & Co-Founder of Strand Life Sciences, stated, “Our mission is to advance genetic diagnostics and ensure it is accessible to everyone. With the StrandOmics Portal, we empower doctors with cutting-edge tools to combat rare diseases more effectively.”
Read this also…Join the Green Movement: Mindspace Eco Run on March 2nd
This initiative underscores Strand Life Sciences’ commitment to innovation and accessibility in genetic healthcare.